Pursuant Regulation 74(5) of the Securities and Exchange Board of India (Depositories & Participants) Regulations, 2018, Dr Lalchandani Labs has enclosed a Certificate, received from registrar and share transfer agent of the Company, for the quarter ended September 30, 2023.
The above information is a part of company’s filings submitted to BSE.